Recurrent airway obstruction (heaves) and summer-pasture-associated obstructive pulmonary disease

Equine Respiratory Medicine and Surgery

Volumn , Issue , 2007, Pages 565-589

  Lavoie, Jean Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650346445     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2759-8.50046-5     Document Type: Chapter

References (148)

1. Abraham G, Brodde OE, Ungemach FR Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone. Equine Veterinary Journal 2002, 34:587-593.
2. Aggarwal N, Holmes MA Characterisation of equine T helper cells: demonstration of Th1- and Th2-like cells in long-term equine T-cell cultures. Research in Veterinary Science 1999, 66:277-279.
3. Ainsworth DM, Eicker SW, Bennett BJ Outcome of horses diagnosed with and treated for heaves 1998, World Equine Airway Symposium, Guelph, Canada.
4. Ainsworth DM, Grunig G, Matychak MB, et al. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology 2003, 96:83-89.
5. Al-Dewachi O, Joubert P, Taha R et al 2002 Expression of IL-5 and IL-9 receptors on neutrophils in horses with heaves. 98th International Conference, American Thoracic Society, Atlanta, GA.
6. Ammann VJ, Vrins AA, Lavoie JP Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD). Equine Veterinary Journal 1998, 30:152-157.
7. Barnes PJ Theophylline: new perspectives for an old drug. American Journal of Respiratory and Critical Care Medicine 2003, 167:813-818.
8. Beadle RE Summer pasture-associated obstructive pulmonary disease. Current Therapy in Equine Medicine 1983, 512-516. WB Saunders, Philadelphia. N.E. Robinson (Ed.).
9. Beadle RE 1985 Experiences with whole-body plethysmography in horses with obstructive pulmonary disease. Lung Function and Respiratory Diseases in the Horse, International Symposium in Hannover, Germany.
10. Beadle RE, Horohov DW, Gaunt SD Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses. Equine Veterinary Journal 2002, 34:389-394.
11. Beech J Chronic obstructive pulmonary disease. Veterinary Clinics of North America; Equine Practice 1991, 7:79-91.
12. Bober LA, Waters TA, Pugliese-Sivo CC, et al. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clinical and Experimental Immunology 1995, 99:129-136.
13. Boey H, Rosenbaum R, Castracane J, et al. Interleukin-4 is a neutrophil activator. Journal of Allergy and Clinical Immunology 1989, 83:978-984.
14. Bowles KS, Beadle RE, Mouch S, et al. A novel model for equine recurrent airway obstruction. Veterinary Immunology and Immunopathology 2002, 87:385-389.
15. Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine 2000, 161:1314-1321.
16. Bureau F, Delhalle S, Bonizzi G, et al. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. Journal of Immunology 2000, 165:5822-5830.
17. Cesarini C, Hamilton E, Picandet V et al 2004 Efficacy of theophylline associated with a low dose of dexamethasone in the treatment of horses with heaves. 22th Symposium of the Veterinary Comparative Respiratory Society, Montreal, Canada.
18. Clarke AF, Madelin TM, Allpress RG The relationship of air hygiene in stables to lower airway disease and pharyngeal lymphoid hyperplasia in two groups of Thoroughbred horses. Equine Veterinary Journal 1987, 19:524-530.
19. Cordeau ME, Joubert P, Dewachi O, et al. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Veterinary Immunology and Immunopathology 2004, 97:87-96.
20. Cornelisse CJ, Robinson NE, Berney CE, et al. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Equine Veterinary Journal 2004, 36:426-430.
21. Costa LR, Seahorn TL, Moore RM, et al. Correlation of clinical score, intrapleural pressure, cytological findings of bronchoalveolar fluid, and histopathological lesions of pulmonary tissue in horses with summer pasture-associated obstructive pulmonary disease. American Journal of Veterinary Research 2000, 61:167-173.
22. Costa LR, Seahorn TL, Moore RM, et al. Plasma and bronchoalveolar fluid concentrations of nitric oxide and localization of nitric oxide synthesis in the lungs of horses with summer pasture-associated obstructive pulmonary disease. American Journal of Veterinary Research 2001, 62:1381-1386.
23. Couetil LL, Ward MP Analysis of risk factors for recurrent airway obstruction in North American horses: 1,444 cases (1990-1999). Journal of the American Veterinary Medical Association 2003, 223:1645-1650.
24. Couetil LL, Rosenthal FS, Simpson CM Forced expiration: a test for airflow obstruction in horses. Journal of Applied Physiology 2000, 88:1870-1879.
25. Deaton CM, Marlin DJ, Smith NC, et al. Pulmonary epithelial lining fluid and plasma ascorbic acid concentrations in horses affected by recurrent airway obstruction. American Journal of Veterinary Research 2004, 65:80-87.
26. Debrue M, Lajoie-Kadoch S, Joubert P et al 2004 Stabling is associated with increased expression of IL-17 mRNA in bronchoalveolar cells of horses with heaves. 100th International Conference, American Thoracic Society, Orlando, FL.
27. Deegen E Massive intravenous infusions: a novel secretolytic therapy for horses with chronic obstructive pulmonary disease (COPD). Proceedings of the American Association of Equine Practitioners 1981, 27:27-33.
28. Derksen FJ, Robinson NE, Armstrong PJ, et al. Airway reactivity in ponies with recurrent airway obstruction (heaves). Journal of Applied Physiology 1985, 58:598-604.
29. Derksen FJ, Robinson NE, Scott JS, et al. Aerosolized Micropolyspora faeni antigen as a cause of pulmonary dysfunction in ponies with recurrent airway obstruction (heaves). American Journal of Veterinary Research 1988, 49:933-938.
30. Derksen FJ, Brown CM, Sonea I, et al. Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine Veterinary Journal 1989, 21:23-26.
31. Derksen FJ, Olszewski M, Robinson NE, et al. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with "heaves". Equine Veterinary Journal 1996, 28:306-310.
32. Dixon PM, Nicholls JR, McPherson EA, et al. Chronic obstructive pulmonary disease anatomical cardiac studies. Equine Veterinary Journal 1982, 14:80-82.
33. Dixon PM, Railton DI, McGorum BC, et al. Equine pulmonary disease: a case control study of 300 referred cases. Part 4: Treatments and re-examination findings. Equine Veterinary Journal 1995, 27:436-439.
34. Dun F Veterinary Medicines: Their Actions and Uses 1859, Sutherland and Knox, Edinburgh.
35. Duvivier DH, Bayly WM, Votion D, et al. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD. Equine Veterinary Journal 1999, 31:20-24.
36. Eder C, Crameri R, Mayer C, et al. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Veterinary Immunology and Immunopathology 2000, 73:241-253.
37. Eder C, Curik I, Brem G, et al. Influence of environmental and genetic factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses. Equine Veterinary Journal 2001, 33:714-720.
38. Erichsen DF, Aviad AD, Schultz RH, et al. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD). Equine Veterinary Journal 1994, 26:331-336.
39. Eyre P Equine pulmonary emphysema: a bronchopulmonary mould allergy. Veterinary Record 1972, 91:134-140.
40. Fairbairn SM, Lees P, Page CP, et al. Duration of antigen-induced hyperresponsiveness in horses with allergic respiratory disease and possible links with early airway obstruction. Journal of Veterinary Pharmacology and Therapeutics 1993, 16:469-476.
41. Fairbairn SM, Page CP, Lees P, et al. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clinical and Experimental Allergy 1993, 23:821-828.
42. Franchini M, Gilli U, Akens MK, et al. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Veterinary Immunology and Immunopathology 1998, 66:53-65.
43. Franchini M, Gill U, von Fellenberg R, et al. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. American Journal of Veterinary Research 2000, 61:1369-1374.
44. Gallivan GJ, McDonell WN An evaluation of the multi-breath nitrogen washout as pulmonary function test in dairy cattle. Canadian Journal of Veterinary Research 1989, 53:133-142.
45. Genetzky RM, Loparco FV Chronic obstructive pulmonary disease in horses: Part 1. Compendium on Continuing Education for the Practicing Veterinarian 1985, 7:S407-S414.
46. George LW, Tanner ML, Roberson EL, et al. Chronic respiratory disease in a horse infected with Dictyocaulus arnfieldi. Journal of the American Veterinary Medical Association 1981, 179:820-822.
47. Gerber H Chronic pulmonary disease in the horse. Equine Veterinary Journal 1973, 5:26-31.
48. Gerber V, King M, Schneider DA, et al. Tracheobronchial mucus viscoelasticity during environmental challenge in horses with recurrent airway obstruction. Equine Veterinary Journal 2000, 32:411-417.
49. Gerber V, Robinson NE, Venta RJ, et al. Mucin genes in horse airways: MUC5AC, but not MUC2, may play a role in recurrent airway obstruction. Equine Veterinary Journal 2003, 35:252-257.
50. Giguere S, Viel L, Lee E 2000 Cytokine messenger RNA (mRNA) expression in bronchoalveolar cells from normal horses and horses with heaves, and effect of therapy with inhaled fluticasone propionate. 18th Annual Veterinary Medical Forum, ACVIM, Seattle, WA.
51. Giguere S, Viel L, Lee E, et al. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology 2002, 85:147-158.
52. Gilleece MH, Scarffe JH, Ghosh A, et al. Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections - a phase I dose toxicity trial. British Journal of Cancer 1992, 66:204-210.
53. Girard D, Paquin R, Beaulieu AD Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochemical Journal 1997, 325:147-153.
54. Grünig G, Herman M, Howald B, et al. Partial divergence between airway inflammation and clinical signs in equine chronic pulmonary disease. Equine Veterinary Journal 1989, 21:145-148.
55. Halliwell RE, Fleischman JB, Mackay-Smith M, et al. The role of allergy in chronic pulmonary disease of horses. Journal of the American Veterinary Medical Association 1979, 174:277-281.
56. Halliwell REW, McGorum BC, Irving P, et al. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Veterinary Immunology and Immunopathology 1993, 38:201-215.
57. Hare JE, Viel L, Conlon PD, et al. In vitro allergen-induced degranulation of pulmonary mast cells from horses with recurrent airway obstruction (heaves). American Journal of Veterinary Research 1999, 60:841-847.
58. Henrikson SL, Rush BR Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. Journal of the American Veterinary Medical Association 2001, 218:1961-1965.
59. Herszberg B, Ramos-Barbon D, Martin JG et al 2004 Airway smooth muscle remodeling in an equine model of chronic asthma. 100th International Conference, American Thoracic Society, Orlando, FL.
60. Hoffman A, Kuehn H, Riedelberger K, et al. Flowmetric comparison of respiratory inductance plethysmography and pneumotachography in horses. Journal of Applied Physiology 2001, 91:2767-2775.
61. Holcombe SJ, Jackson C, Gerber V, et al. Stabling is associated with airway inflammation in young Arabian horses. Equine Veterinary Journal 2001, 33:244-249.
62. Jean D 1996 Etude de la variabilité des valeurs de mécanique respiratoire et de la cytologie du lavage bronchoalveolaire chez les chevaux atteints de maladie pulmonaire obstructive chronique (MPOC) et de chevaux exempts de cette maladie. MSc thesis, Faculté des Études Supérieures, St-Hyacinthe, Université de Montréal.
63. Jean D, Vrins A, Lavoie JP Respiratory and metabolic effects of massive administration of isotonic saline solution in heaves-affected and control horses. Equine Veterinary Journal 2004, 36:628-633.
64. Jefcoat AM, Hotchkiss JA, Gerber V, et al. Persistent mucin glycoprotein alterations in equine recurrent airway obstruction. American Journal of Physiology. Cell Physiology 2001, 281:C704-C712.
65. Joubert P, Silversides DW, Lavoie JP Equine neutrophils express mRNA for tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-gamma. Equine Veterinary Journal 2001, 33:730-733.
66. Joubert P, Cordeau ME, Boyer A et al 2002 Quantification of cytokine mRNA expression by pulmonary macrophages in horses affected by heaves. 20th Symposium of the Veterinary Comparative Respiratory Society, Boston, MA.
67. Kaup F-J, Drommer W, Damsch S, et al. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). 2: Pathological changes of the terminal airways and the alveolar region. Equine Veterinary Journal 1990, 22:349-355.
68. Kirschvink N, Fievez L, Bougnet V, et al. Effect of nutritional antioxidant supplementation on systemic and pulmonary antioxidant status, airway inflammation and lung function in heaves-affected horses. Equine Veterinary Journal 2002, 34:705-712.
69. Kolm G, Zappe H, Schmid R, et al. Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses. Veterinary Record 2003, 152:804-806.
70. Kvart C, Carlsen J, Dahl L et al 1986 Changes in arterial oxygen tension in COPD horses after reduction of exposure to dust in the feed and environment. Second International Conference on Equine Exercise Physiology, San Diego, LA. ICEEP Publications.
71. Lapointe JM, Lavoie JP, Vrins AA Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. American Journal of Veterinary Research 1993, 54:1310-1316.
72. Larson VL, Busch RH Equine tracheobronchial lavage: comparison of lavage cytologic and pulmonary histopathologic findings. American Journal of Veterinary Research 1985, 46:144-146.
73. Lasky JA, Brody AR Interleukins involved in the pathogenesis of chronic airway inflammation. Research in Immunology 1997, 148:39-47.
74. Lavoie JP, Maghni K, Desnoyers M, et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine 2001, 164:1410-1413.
75. Lavoie JP, Pasloske K, Joubert P et al 2002a Comparison of dexamethasone and the PDE IV enzyme inhibitor L826-141 in an animal model of chronic asthma. 98th International Conference, American Thoracic Society, Atlanta, GA.
76. Lavoie JP, Leguillette R, Pasloske K, et al. Comparison of dexamethasone and the LTD4 receptor antagonist L-708,738 on lung function and airway cytology in heaves. American Journal of Veterinary Research 2002, 63:579-585.
77. Lavoie JP, Dalle S, Breton L, et al. Bronchiectasis in three adult horses with heaves. Journal of Veterinary Internal Medicine 2004, 18:757-760.
78. Lawson GHK, McPherson EA, Murphy JR, et al. The presence of precipitating antibodies in the sera of horses with chronic obstructive pulmonary disease (COPD). Equine Veterinary Journal 1979, 11:172-176.
79. Leguillette R, Désévaux C, Lavoie JP Effects of pentoxifylline on pulmonary function and results of cytologic examination of bronchoalveolar lavage fluid in horses with recurrent airway obstruction. American Journal of Veterinary Research 2002, 63:459-463.
80. Lorch G, Hillier A, Kwochka RW, et al. Comparison of immediate intradermal test reactivity with serum IgE quantitation by use of a radioallergosorbent test and two ELISA in horses with and without atopy. Journal of the American Veterinary Medical Association 2001, 218:1314-1322.
81. Lowell F Observations on heaves: an asthma-like syndrome in the horse. Journal of Allergy 1964, 35:322-330.
82. Mair TS Bacterial pneumonia associated with corticosteroid therapy in three horses. Veterinary Record 1996, 138:205-207.
83. Mair TS Obstructive pulmonary disease in 18 horses at summer pasture. Veterinary Record 1996, 138:89-91.
84. Malikides N 2004 The epidemiology of inflammatory airway disease in young thoroughbred racehorses in Australia. PhD thesis, University of Sydney, Australia.
85. Mansmann RA, Osburn BI, Wheat JD, et al. Chicken hypersensitivity pneumonitis in horses. Journal of the American Veterinary Medical Association 1975, 166:673-677.
86. Marr KA, Foster AP, Lees P, et al. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. Research in Veterinary Science 1997, 62:253-260.
87. Marr KA, Lees P, Page CP, et al. Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease. Journal of Veterinary Pharmacology and Therapeutics 1998, 21:241-246.
88. Marr KA, Lees P, Page CP, et al. Inhaled leukotrienes cause bronchoconstriction and neutrophil accumulation in horses. Research in Veterinary Science 1998, 64:219-224.
89. Marti E, Gerber H, Essich G, et al. The genetic basis of equine allergic diseases. 1. Chronic hypersensitivity bronchitis. Equine Veterinary Journal 1991, 23:457-460.
90. Mazan MR, Hoffman AM, Manjerovic N Comparison of forced oscillation with the conventional method for histamine bronchoprovocation testing in horses. American Journal of Veterinary Research 1999, 60:174-180.
91. Mazan MR, Deveney EF, DeWitt S, et al. Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction. Journal of Applied Physiology 2004, 97:91-97.
92. McGorum BC, Dixon PM, Halliwell RE, et al. Comparison of cellular and molecular components of bronchoalveolar lavage fluid harvested from different segments of the equine lung. Research in Veterinary Science 1993, 55:57-59.
93. McGorum BC, Dixon PM, Halliwell REW Quantification of histamine in plasma and pulmonary fluids from horses with chronic obstructive pulmonary disease, before and after natural (hay and straw) challenges. Veterinary Immunology and Immunopathology 1993, 36:223-237.
94. McKiernan BC, Koritz GD Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease. Equine Veterinary Journal 1990, 22:194-197.
95. McPherson EA, Lawson GHK, Murphy JR, et al. Chronic obstructive pulmonary disease (COPD): identification of affected horses. Equine Veterinary Journal 1978, 10:47-53.
96. McPherson EA, Lawson GH, Murphy JR, et al. Chronic obstructive pulmonary disease (COPD): factors influencing the occurrence. Equine Veterinary Journal 1979, 11:167-171.
97. McPherson EA, Lawson GHK, Murphy JR, et al. Chronic obstructive pulmonary disease (COPD) in horses: aetiological studies: responses to intradermal and inhalation antigenic challenge. Equine Veterinary Journal 1979, 11:159-166.
98. Murphy JR, McPherson EA, Dixon PM Chronic obstructive pulmonary disease (COPD): Effects of bronchodilator drugs on normal and affected horses. Equine Veterinary Journal 1980, 12:10-14.
99. Naylor JM, Clark EG, Clayton HM Chronic obstructive pulmonary disease: usefulness of clinical signs, bronchoalveolar lavage, and lung biopsy as diagnostic and prognostic aids. Canadian Veterinary Journal 1992, 33:591-598.
100. Nuytten J, Deprez P, Picavet T, et al. Comparison of different pulmonary function tests and their prognostic value in horses affected with COPD. Equine Veterinary Science 1988, 8:361-364.
101. Nyman G, Linderg R, Weckner D, et al. Pulmonary gas exchange correlate to clinical signs and lung pathology in horses with chronic bronchiolitis. Equine Veterinary Journal 1991, 23:253-260.
102. Obel N, Schmiterlöw C The action of histamine and other drugs on the bronchial tone of horses suffering from alveolar emphysema (heaves). Acta Pharmacologica Sinica 1948, 4:71-80.
103. Olszewski MA, Robinson NE, Zhu FX, et al. Mediators of anaphylaxis but not activated neutrophils augment cholinergic responses of equine small airways. American Journal of Physiology 1999, 276:L522-L529.
104. Pearson EG, Riebold TW Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. Journal of the American Veterinary Medical Association 1989, 194:1287-1291.
105. Pellegrini A, Kalkinc M, Hermann M, et al. Equinins in equine neutrophils: quantification in tracheobronchial secretions as an aid in the diagnosis of chronic pulmonary disease. Veterinary Journal 1998, 155:257-262.
106. Peroni DL, Stanley S, Kollias-Baker C, et al. Prednisone per os is likely to have limited efficacy in horses. Equine Veterinary Journal 2002, 34:283-287.
107. Picandet V, Leguillette R, Lavoie JP Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ("heaves"). Equine Veterinary Journal 2003, 35:419-424.
108. Picandet V, Jean D, Lavoie JP 2004 Acid base balance in arterial blood of horses with heaves. 22nd Veterinary and Comparative Respiratory Symposium, Montreal, Canada.
109. Pirie RS, Dixon PM, Collie DD, et al. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Veterinary Journal 2001, 33:311-318.
110. Pirie RS, Collie DD, Dixon PM, et al. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 2: Effects of inhaled HDS on control and heaves horses. Equine Veterinary Journal 2002, 34:337-342.
111. Robinson NE International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Veterinary Journal 2001, 33:5-19.
112. Robinson NE, Derksen FJ, Berney C, et al. The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine Veterinary Journal 1993, 25:299-303.
113. Robinson NE, Boehler D, Berney C, et al. Failure of a FLAP antagonist to prevent airway obstruction in heaves-susceptible horses 1998, World Equine Airways Symposium, Guelph, Canada.
114. Robinson NE, Olszewski MA, Boehler D, et al. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Veterinary Journal 2000, 32:393-400.
115. Robinson NE, Jackson C, Jefcoat A, et al. Efficacy of three corticosteroids for the treatment of heaves. Equine Veterinary Journal 2002, 34:17-22.
116. Robinson NE, Berney C, Eberhart S, et al. Cough, mucus, airway obstruction, and inflammation in heaves-affected and control horses. American Journal of Veterinary Research 2003, 64:550-557.
117. Rush BR, Flaminio MJ, Matson C et al 1997 Inhaled beclomethasone dipropionate for the treatment of heaves. 15th Symposium of the Veterinary Comparative Respiratory Society, University of Liege, Belgium.
118. Rush BR, Flaminio MJ, Matson CJ, et al. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. American Journal of Veterinary Research 1998, 59:1033-1038.
119. Rush BR, Raub ES, Rhoads WS, et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. American Journal of Veterinary Research 1998, 59:1039-1043.
120. Schmallenbach KH, Rahman I, Sasse HHL, et al. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Veterinary Immunology and Immunopathology 1998, 66:245-256.
121. Seahorn TL, Beadle RE Summer pasture-associated obstructive pulmonary disease in horses - 21 cases (1983-1991). Journal of the American Veterinary Medical Association 1993, 202:779-782.
122. Seahorn TL, Groves MG, Harrington KS, et al. Chronic obstructive pulmonary disease in horses in Louisiana. Journal of the American Veterinary Medical Association 1996, 208:248-251.
123. Seahorn TL, Beadle RE, McGorum BC, et al. Quantification of antigen-specific antibody concentrations in tracheal lavage fluid of horses with summer pasture-associated obstructive pulmonary disease. American Journal of Veterinary Research 1997, 58:1408-1411.
124. Soma LR, Beech J, Gerber NH Effects of cromolyn in horses with chronic obstructive pulmonary disease. Veterinary Research Communications 1987, 11:339-351.
125. Stamper AJ, Rush BR, Wilkerson MJ et al 2002 Glucocorticoid resistance in a horse with heaves. 20th Symposium of the Veterinary Comparative Respiratory Society, Boston, MA.
126. Thomson JR, McPherson EA Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horse. Equine Veterinary Journal 1981, 13:243-246.
127. Thomson JR, McPherson EA Chronic obstructive pulmonary disease in the horse 2: Therapy. Equine Veterinary Journal 1983, 15:207-210.
128. Thomson JR, McPherson EA Effects of environmental control on pulmonary function of horses affected with chronic obstructive pulmonary disease. Equine Veterinary Journal 1984, 16:35-38.
129. Thurlbeck WM, Lowell FC Heaves in horses. American Journal of Respiratory Diseases 1964, 89:82-88.
130. Torneke MK, Ingvast-Larsson JC, Johansson JM, et al. Pharmacokinetics and pharmacodynamics of terbutaline in healthy horses. American Journal of Veterinary Research 2000, 61:761-765.
131. Traub-Dargatz JL, McKinnon AO, Thrall MA, et al. Evaluation of clinical signs of disease, bronchoalveolar and tracheal wash analysis, and arterial blood gas tensions in 13 horses with chronic obstructive pulmonary disease treated with prednisone, methyl sulfonmethane, and clenbuterol hydrochloride. American Journal of Veterinary Research 1992, 53:1908-1916.
132. Tremblay GM, Ferland C, Lapointe J-M, et al. Effect of stabling on bronchoalveolar cells obtained from normal and COPD horses. Equine Veterinary Journal 1993, 25:194-197.
133. Turlej RK, Fievez L, Sandersen CF, et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax 2001, 56:696-702.
134. van den Hoven R, Zappe H, Zitterl-Eglseer K, et al. Study of the effect of Bronchipret on the lung function of five Austrian saddle horses suffering recurrent airway obstruction (heaves). Veterinary Record 2003, 152:555-557.
135. Vandenput S, Istasse L, Nicks B, et al. Airborne dust and aeroallergen concentrations in different sources of feed and bedding for horses. Veterinary Quarterly 1997, 19:154-158.
136. Vandenput S, Votion D, Duvivier DH, et al. Effect of a set stabled environmental control on pulmonary function and airway reactivity of COPD affected horses. Veterinary Journal 1998, 155:189-195.
137. Vandenput S, Duvivier DH, Votion D, et al. Environmental control to maintain stabled COPD horses in clinical remission: effects on pulmonary function. Equine Veterinary Journal 1998, 30:93-96.
138. van Erck E, Votion DM, Kirschvink N, et al. Use of the impulse oscillometry system for testing pulmonary function during methacholine bronchoprovocation in horses. American Journal of Veterinary Research 2003, 64:1414-1420.
139. Viel L 1983 Structural-functional correlations of the lung in horses with small airway disease. PhD thesis, University of Guelph.
140. Votion DM, Vandenput SN, Duvivier DH, et al. Alveolar clearance in horses with chronic obstructive pulmonary disease. American Journal of Veterinary Research 1999, 60:495-500.
141. Vrins A, Doucet M, Nunez-Ochoa L A retrospective study of bronchoalveolar lavage cytology in horses with clinical findings of small airway disease. Zentralblatt fur Veterinarmedizin A 1991, 38:472-479.
142. Watson ED, Sweeney CR, Steensma KA Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD. Equine Veterinary Journal 1992, 24:379-381.
143. Willoughby RA, McDonnel WN Pulmonary function testing in horses. Veterinary Clinics of North America; Large Animal Practice 1979, 1:171-196.
144. Winder NC, von Fellenberg R Chronic small airway disease in horses slaughtered in Switzerland. Schweizer Archiv fur Tierheilkunde 1987, 129:585-593.
145. Winder NC, Hermann M, Grünig G, et al. Comparison of bronchoalveolar lavage and respiratory secretion cytology in horses with clinically diagnosed chronic pulmonary disease. Schweizer Archiv fur Tierheilkunde 1990, 132:505-510.
146. Woods PS, Robinson NE, Swanson MC, et al. Airborne dust and aeroallergen concentration in a horse stable under two different management systems. Equine Veterinary Journal 1993, 25:208-213.
147. Yang L, Cohn L, Zhang DH, et al. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. Journal of Experimental Medicine 1998, 188:1739-1750.
148. Yu MF, Wang ZW, Robinson NE, et al. Modulation of bronchial smooth muscle function in horses with heaves. Journal of Applied Physiology 1994, 77:2149-2154.